摘要
目的统计分析中国多地区2023年度减重与代谢手术开展情况。方法基于大中华减重与代谢手术数据库数据登记工作,统计分析2023年度各地区开展减重与代谢手术情况,并对病人人口学信息、肥胖相关疾病、手术信息等进行统计学描述和分析。结果2023年度,来自21个省(自治区、直辖市)共62家中心上传临床数据至大中华减重与代谢手术数据库,登记有效病例10525例。术前中位体重指数(BMI)为37.9(25.0,80.1)。女性病人7430例(71.1%),年龄中位数为33(8,80)岁;男性病人3027例(28.9%),年龄中位数为32(10,72)岁。27.4%的病人在术前合并2型糖尿病,90.6%的病人术前合并脂肪性肝病,51.7%的病人术前合并高血压病,57.3%的病人术前合并阻塞性睡眠呼吸暂停低通气综合征,18.5%的女性病人术前合并多囊卵巢综合征,25.5%的病人术前合并反流性食管炎。行胃袖状切除术(SG)占87.74%,胃袖状切除联合空肠空肠旁路术(SG-JJB)占4.91%,单吻合口胃旁路术(OAGB)占2.67%,胃袖状切除联合双通道术(SG-TB)占2.19%,Roux-en-Y胃旁路术(RYGB)占1.64%,胃袖状切除联合单吻合口十二指肠回肠旁路术/单吻合口十二指肠转位术(SADI-S/OADS)占0.67%,胃袖状切除联合袢式十二指肠空肠旁路术(SG-LDJB)占0.07%,胃袖状切除联合十二指肠空肠旁路术(SG-DJB)占0.01%,其他手术方式占0.10%。结论通过对2023年度数据报告分析,中国接受减重与代谢手术病人主要以中青年为主,女性病人居多,术前合并肥胖相关疾病占比高,SG仍为主流术式。2023年度报告研究反映了中国减重与代谢外科学科发展动态,为与既往年度数据、国际数据对比提供了重要基础。
Objective To summarize the metabolic and bariatric surgery cases performed in China in 2023.Methods The data of this observational study was extracted from the Greater China Metabolic and Bariatric Surgery Database(GC-MBD)to evaluate the prevalence of metabolic and bariatric surgery in China.Demographic characteristics,obesity-related diseases and surgery information were analyzed.Results In 2023,62 centers from 21 provinces/province-level municipalities in China registered a total of 10525 cases.The patients’median(minimum,maximum)BMI before the surgery was 37.9(25.0,80.1).The proportion of female patients was 71.1%,with a median(minimum,maximum)age of 33(8,80)years,while the proportion of males was 28.9%,with a median(minimum,maximum)age of 32(10,72)years.In addition,27.4% of patients had a history of type 2 diabetes,90.6% of patients had a history of fatty liver disease,51.7% had a history of hypertension,57.3% of obstructive sleep apnea hypopnea syndrome(OSAHS),18.5% polycystic ovary syndrome(PCOS)in female patients,25.5% reflux esophagitis(RE)before operation.Among all procedures,87.74% were sleeve gastrectomy(SG),4.91%sleeve gastrectomy with jejunojenunal bypass(SG-JJB),2.67% one anastomosis gastric bypass(OAGB),2.19%sleeve gastrectomy with transit bipartition(SG-TB),1.64% Roux-en-Y gastric bypass(RYGB),0.67%single-anastomosis duodenal-ileal bypass with sleeve gastrectomy/one anatomosis duodenal switch(SADI-S/OADS),0.07%sleeve gastrectomy with loop duodenojejunal bypass(SG-LDJB),0.01%sleeve gastrectomy with duodenojejunal bypass(SG-DJB),and 0.10% other operation types.Conclusion Based on the analysis of the year 2023 data,this report summarized the clinical characteristics and practice status in patients who underwent metabolic and bariatric surgery,mainly manifested as high BMI levels,the majority of female patients,a high proportions of obesity-related diseases before surgery,and SG still being the mainstream surgical procedure in China.This study reflects the disciplinary development trends of metabolic and bariatric surgery in China,providing an important basis for comparison with previous annual and international data.
出处
《中国实用外科杂志》
CAS
CSCD
北大核心
2024年第5期552-563,570,共13页
Chinese Journal of Practical Surgery
基金
国家科技支撑计划课题(No.2015BA113B09)。
关键词
减重与代谢手术
数据库
年度报告
肥胖
metabolic and bariatric surgery
clinical database
registry report
obesity
